Research
Comparison of Once-Daily Triple Therapy versus Conventional Triple Therapy for Patient Compliance and the Eradication of Helicobacter pylori Infection
Author(s): Naila Mohiuddin*, Sumaiya Al Hajree, Ruqiya Fatima, Mohammed Mustaneer Akmal, Syed Ibrahim Hassan, Asif Rasheed and Aleem Ahmed Khan
Aim: To compare the effectiveness of once-daily triple therapy with conventional triple therapy for the eradication
of H. pylori. Materials and methods: A prospective comparative study in the gastroenterology unit of a tertiary
care hospital was conducted for 6 months. 180 patients with active peptic disease tested positive for rapid urease
test or 13C-UBT and concomitantly positive for anti-H. pylori antibodies IgG and IgM were given either once-daily
(Tinidazole 1000 mg+Azithromycin 500 mg+Rabeprazole 40 mg) or twice-daily (Amoxicillin 500 mg+Clarithromycin
500 mg+Esomeprazole 40 mg) first-line therapy for ten days. Ten weeks after the completion of therapy rapid urease
test and 13C-UBT were repeated. Adherence and adverse events were evaluated using pill count, structured questionnaires,
and exit interviews... Read More»
Select your language of interest to view the total content in your interested language